Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
01/2003
01/21/2003US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production
01/21/2003US6509151 DNA molecule encoding a Mycobacterium protein and conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages
01/21/2003CA2100159C Rapid assays for amplification products
01/16/2003WO2003004691A2 Regulators of biofilm formation and uses thereof
01/16/2003WO2003004689A2 Regulators of biofilm formation and uses thereof
01/16/2003WO2003004686A2 Fluorescence-based assay for the detection of specific nucleic acids using photon counting
01/16/2003WO2003004602A2 Nuclease resistant chimeric oligonucleotides
01/16/2003WO2003004512A1 Activators for oligonucleotide synthesis
01/16/2003WO2003004511A2 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
01/16/2003WO2003003904A2 Coactivators in the diagnosis and treatment of breast cancer
01/16/2003WO2002030944A3 Fluorescent nucleobase conjugates having anionic linkers
01/16/2003WO2002030266A3 Detection of dna damage
01/16/2003WO2001059093A9 Full-length infectious cdna clones of tick borne flavivirus
01/16/2003US20030014770 Alpha (1,3) galactosyl transferase negative swine
01/16/2003US20030013869 Esters of cyclic ADP ribose derivatives
01/16/2003US20030013868 C-3' protected monomeric nucleotides and synthesis of oligonucleotides on solid support
01/16/2003US20030013864 Method for the synthesis of nucleotide of oligonucleotide phosphoramidites
01/16/2003US20030013857 Crosslinking and immobilizing biomolecules, drugs and synthetic polymers with a thiol or amino reactive group and hydrazino or oxyamino moieties
01/16/2003US20030013855 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/16/2003US20030013674 Gene therapy; in situ supplying of genes; nucleic acid complex
01/16/2003US20030013670 Antisense oligonucleotide inhibition of ras
01/16/2003US20030013668 Antiarthritic agents; inflammatory bowel disease; multiple sclerosis
01/16/2003US20030013649 Hybrid polypeptide
01/16/2003US20030013174 Genes for lysine biosynthetic system derived from thermophilic bacteria
01/16/2003US20030013153 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/16/2003US20030013149 Quantitative analysis
01/16/2003US20030013124 Solid support for use in monitoring hybridization reactions
01/16/2003US20030013117 Separation of nucleotide sequences in preferential pools; obtain nucleotide sequences, incubate with sequestering agents, separate reaction mixture, release pools of nucleotide sequences
01/16/2003US20030013100 Nucleic acid reading and analysis system
01/16/2003US20030013089 Compound for use as a diagnostic tool in nucleotide sequencing
01/16/2003US20030012790 Especially bispecific molecules comprising an IFN- gamma inhibitor and a further specificity to a target involved in the initiation or development of IBD, including ulcerative colitis and Crohn's disease.
01/16/2003US20030012787 Especially for ulcerative colitis and Crohn's disease.
01/16/2003DE20023055U1 Photolithographic exposure unit for e.g. manufacturing DNA chips, scans target areas of biological material selectively with highly-focused flying spot illumination
01/16/2003CA2798555A1 Methods for detection and quantification of analytes in complex mixtures
01/16/2003CA2452458A1 Nuclease resistant chimeric oligonucleotides
01/16/2003CA2451738A1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine
01/15/2003EP1275737A2 Compositions and processes for analyte detection; quantification and amplification
01/15/2003EP1275655A1 Silicon-containing linkers for nucleic acid mass markers
01/15/2003EP1275004A2 Mass labels
01/15/2003EP1274834A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
01/15/2003EP1274661A1 Polymer coated surfaces for microarray applications
01/15/2003EP1171635A4 Electronically mediated nucleic acid amplification in nasba
01/15/2003EP1015627A4 Method for detecting a target compound using a nucleic acid ligand
01/15/2003EP0958376A4 Prolactin receptor gene as a genetic marker for increased litter size in pigs
01/15/2003EP0667920B1 Methods of detecting micrometastasis of prostate cancer
01/15/2003CN1390940A 4-coumaric acid: CoA ligase gene and its clone
01/15/2003CN1390938A hMCP-DAF fusion gene and its polypeptide coded by it and configuring process
01/15/2003CN1390935A Human hematolysis associated membrane protein and its coding sequence, preparing process and usage
01/15/2003CN1390852A Human auricular fibrillation pathogene and coding protein and its usage
01/15/2003CN1390851A Bombesin of Bombina maxima and its preparing process and genes
01/15/2003CN1390850A Neurotrophic factor of Bombina maxima and its preparing process and genes
01/15/2003CN1390849A Neurotrophic peptide of Bombina maxima and its preparing process and genes
01/15/2003CN1390848A Bradykinin of Bombina maxima and its preparing process and genes
01/15/2003CN1390847A Salmon's calcitonin gene synthesized by plant preference codon and its application
01/14/2003US6506962 Disease resistance
01/14/2003US6506896 Conjugated to peptides, proteins, nucleic acids, antibodies, RNA, or DNA; medical diagnosis, electronics
01/14/2003US6506895 Photoactivatable nucleic acids
01/14/2003US6506894 Solution phase synthesis of oligonucleotides
01/14/2003US6506893 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
01/14/2003US6506890 Adding polycation to prevent aggregation; automatic
01/14/2003US6506888 Viricides, antitumor and anticarcinogenic agents
01/14/2003US6506883 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use
01/14/2003US6506735 Optimized antisense oligonucleotides complementary to DNA methyltransferase sequences
01/14/2003US6506586 Nucleic acids encoding polypeptides having haloperoxidase activity
01/14/2003US6506585 Polypeptides having haloperoxidase activity
01/14/2003US6506569 Drug screening; genetic engineering
01/14/2003US6506564 Nanoparticles having oligonucleotides attached thereto and uses therefor
01/14/2003US6506563 Multiparametric fluorescence in situ hybridization
01/14/2003US6506560 Cloned DNA polymerases from Thermotoga and mutants thereof
01/14/2003US6506558 Deprotecting nucleoside, nucleotide or amino acid to form polypeptide or polynucleotide
01/14/2003CA2141494C Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof
01/09/2003WO2003002746A2 Perv screening method and use thereof
01/09/2003WO2003002715A2 Compositions and methods for labeling oligonucleotides
01/09/2003WO2003002633A1 Synthesis and use of organosilica particles
01/09/2003WO2003002587A2 Phosphoramide containing nucleic acid-based compounds and libraries as antivirals
01/09/2003WO2002083707A9 Tub antisense constructs
01/09/2003WO2002078630A8 Tub 3'-variant
01/09/2003WO2002032943A3 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
01/09/2003WO2002031142A3 Antisense nucleic acid against alphav integrin
01/09/2003WO2002012566A3 The use and evaluation of a [2+2] photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix
01/09/2003WO2002000618A3 Progesterone receptor-regulated gene expression and methods related thereto
01/09/2003US20030009027 Covalently attaching a first nucleotide or an oligonucleotide via a C-5' oxygen of the nucleotide to the substrate for producing an immobilized oligonucleotide on a substrate
01/09/2003US20030009013 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/09/2003US20030009012 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/09/2003US20030008837 Therapy
01/09/2003US20030008834 Compsoitions and methods for treating epithelia and retinal tissue diseases
01/09/2003US20030008815 For diagnosis and therapy of immune related disease in mammals, including humans; tumor therapy
01/09/2003US20030008386 Generation of solid supports; obtain reaction mixture, dispense uniformly on solid support, form layers
01/09/2003US20030008353 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors
01/09/2003US20030008352 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/09/2003US20030008345 Expression augmenting sequence elements (EASE) for eukaryotic expression systems
01/09/2003US20030008339 Detection of preferential particles in sample; obtain reaction mixture, incubate with binding particles, detect complex, monitor and measure luminescence
01/09/2003US20030008320 Isolation of nucleic acids
01/09/2003US20030008318 Determination of the number of copies of a preferential nucleotide sequence in sample; obtain sample, incubate with solid support and probe, detecting the amount of binding of the first and second labelled complementary
01/09/2003US20030008316 Anthraquinone and its derivatives
01/09/2003US20030008312 Provision of DNA investigating tools
01/09/2003US20030008304 Fluorescent quenching detection reagents and methods
01/09/2003US20030008302 Sequencing of surface immobilized polymers utilizing microfluorescence detection
01/09/2003US20030008297 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/09/2003CA2491110A1 Synthesis and use of organosilica particles